Cybrexa Therapeutics

We’re passionate about improving patient outcomes and saving lives by developing the next generation of cancer therapeutics that specifically target tumors and their underlying biology.

alphalex™ is a tumor targeting platform.

Cybrexa alphalex powers new applications and combinations of existing cancer therapeutics using an elegant approach for targeted intracellular drug delivery, independent of surface antigens. Leveraging alphalex, we are passionate about discovering new ways to effectively treat cancer and meaningfully improve lives.